Biote Investors Sue Cooley, SPAC After Huge Merger Loss <https://www.law360.com/legalethics/articles/1845076?nl_pk=153d4a8a-6fb9-4a5f-b7aa-0651cdd34b32&utm_source=newsletter&utm_medium=email&utm_campaign=legalethics&utm_content=2024-06-07&read_main=1&nlsidx=0&nlaidx=2> By Katryna Perera Family trust investors in Biote Corp. have sued Cooley LLP and the "hormone optimization" company's top brass over the $700 million merger Biote completed with a special purpose acquisition company, saying the deal was a "disastrous transaction to divert approximately $70 million of merger consideration to themselves and gain control of an enterprise they did not build." Read full article » <https://www.law360.com/legalethics/articles/1845076?nl_pk=153d4a8a-6fb9-4a5f-b7aa-0651cdd34b32&utm_source=newsletter&utm_medium=email&utm_campaign=legalethics&utm_content=2024-06-07&read_more=1&nlsidx=0&nlaidx=2> | Save to favorites » <https://www.law360.com/legalethics/articles/1845076?nl_pk=153d4a8a-6fb9-4a5f-b7aa-0651cdd34b32&utm_source=newsletter&utm_medium=email&utm_campaign=legalethics&utm_content=2024-06-07&read_later=1&nlsidx=0&nlaidx=2>